Skip to main content
. 2021 Oct 30;10(21):5101. doi: 10.3390/jcm10215101

Table 5.

Clinical outcomes during the whole follow-up in the matched cohort of patients with AF and prevalent or incident HF with follow-up starting at the time of last event between AF or HF.

Prevalent HF
(n = 212,293)
Incident HF
(n = 212,293)
HR (95% CI) for
Prevalent HF
vs. Incident HF
p (Uncorrected) p (Bonferroni Correction)
All-cause death 68,150 (21.6) 64,643 (19.3) 1.10 (1.08–1.11) <0.0001 <0.0001
Cardiovascular death 24,156 (7.7) 21,874 (6.5) 1.14 (1.12–1.16) * <0.0001 <0.0001
Non-cardiovascular death 43,994 (14.0) 42,769 (12.8) 1.07 (1.06–1.09) <0.0001 <0.0001
Ischemic stroke 3775 (1.2) 7824 (2.4) 0.50 (0.48–0.52) <0.0001 <0.0001
Re-hospitalization for HF 49,763 (19.4) 24,785 (13.2) 1.44 (1.41–1.46) <0.0001 <0.0001
Cancer 14,558 (4.9) 15,176 (5.0) 0.97 (0.95–0.99) 0.005 0.02

* hazard ratio = 1.13 (1.11–1.16), uncorrected p < 0.0001, corrected p < 0.0001 by Fine and Gray model for competing risks of cardiovascular and non-cardiovascular death. hazard ratio = 0.48 (0.46–0.50), uncorrected p < 0.0001, corrected p < 0.0001 by Fine and Gray model for competing risks of ischemic stroke and death. Values are n (incidence rate, %/year). AF, atrial fibrillation; CI, confidence interval; HF, heart failure; HR, hazard ratio.